KR20190137904A - 연골형성의 유도 방법 - Google Patents

연골형성의 유도 방법 Download PDF

Info

Publication number
KR20190137904A
KR20190137904A KR1020197034179A KR20197034179A KR20190137904A KR 20190137904 A KR20190137904 A KR 20190137904A KR 1020197034179 A KR1020197034179 A KR 1020197034179A KR 20197034179 A KR20197034179 A KR 20197034179A KR 20190137904 A KR20190137904 A KR 20190137904A
Authority
KR
South Korea
Prior art keywords
compound
pharmaceutically acceptable
administration
benzamide
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020197034179A
Other languages
English (en)
Korean (ko)
Inventor
피터 지 슐츠
아르납 케이 채터지
티모시 엠 라이트
존 위슬러
바딤 클루시니첸코
Original Assignee
더 스크립스 리서치 인스티튜트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 더 스크립스 리서치 인스티튜트 filed Critical 더 스크립스 리서치 인스티튜트
Publication of KR20190137904A publication Critical patent/KR20190137904A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/216—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with other specific functional groups, e.g. aldehydes, ketones, phenols, quaternary phosphonium groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/452—Lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/06—Materials or treatment for tissue regeneration for cartilage reconstruction, e.g. meniscus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/24—Materials or treatment for tissue regeneration for joint reconstruction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Molecular Biology (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1020197034179A 2017-04-24 2018-04-23 연골형성의 유도 방법 Ceased KR20190137904A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762489397P 2017-04-24 2017-04-24
US62/489,397 2017-04-24
PCT/US2018/028939 WO2018200411A1 (en) 2017-04-24 2018-04-23 Methods for inducing chondrogenesis

Publications (1)

Publication Number Publication Date
KR20190137904A true KR20190137904A (ko) 2019-12-11

Family

ID=63919101

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020197034179A Ceased KR20190137904A (ko) 2017-04-24 2018-04-23 연골형성의 유도 방법

Country Status (10)

Country Link
US (1) US20210361600A1 (https=)
EP (1) EP3615021A4 (https=)
JP (2) JP2020517597A (https=)
KR (1) KR20190137904A (https=)
CN (1) CN110809468A (https=)
AU (1) AU2018257769A1 (https=)
CA (1) CA3060518A1 (https=)
MA (1) MA48479A (https=)
RU (1) RU2019136884A (https=)
WO (1) WO2018200411A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12186307B2 (en) 2019-02-13 2025-01-07 Yale University Methods of treating epilepsy
FI129515B (en) 2020-11-06 2022-03-31 Salarusta Oy FOR USE IN THE PREVENTION AND / OR TREATMENT OF A DISEASE OR CONDITION RELATED TO THE DEGRADATION AND / OR DISTURBANCE OF THE DEGREE OF MONTOOSASE AND / OR INTEGRITY

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9464065B2 (en) * 2011-03-24 2016-10-11 The Scripps Research Institute Compounds and methods for inducing chondrogenesis
HK1224172A1 (zh) * 2013-03-15 2017-08-18 加州生物医学研究所 用於诱导软骨形成的化合物和方法
DK3143026T3 (da) * 2014-05-13 2024-09-30 Novartis Ag Forbindelser og sammensætninger til induktion af chondrogenese

Also Published As

Publication number Publication date
AU2018257769A1 (en) 2019-11-07
RU2019136884A (ru) 2021-05-25
US20210361600A1 (en) 2021-11-25
JP2023071181A (ja) 2023-05-22
RU2019136884A3 (https=) 2021-08-03
EP3615021A1 (en) 2020-03-04
CA3060518A1 (en) 2018-11-01
WO2018200411A1 (en) 2018-11-01
EP3615021A4 (en) 2020-12-30
JP2020517597A (ja) 2020-06-18
MA48479A (fr) 2020-03-04
CN110809468A (zh) 2020-02-18

Similar Documents

Publication Publication Date Title
US10882860B2 (en) Treatment of osteoarthritis
Gomoll et al. Chondrolysis after continuous intra-articular bupivacaine infusion: an experimental model investigating chondrotoxicity in the rabbit shoulder
JP2021138712A (ja) 老化細胞を殺し、老化関連疾患および障害を処置するための方法と組成物
ES2900815T3 (es) Compuestos y métodos para inducir la condrogénesis
BRPI0616324A2 (pt) formulaÇço de cÁpsula de pirfenidona e excipientes farmaceuticamente aceitÁveis
US20200325148A1 (en) Compositions and methods of treatment for neurological disorders comprising motor neuron diseases
Nirogi et al. SUVN-502, a novel, potent, pure, and orally active 5-HT6 receptor antagonist: pharmacological, behavioral, and neurochemical characterization
US10722493B2 (en) Methods for treating fibroproliferative disorders in a mammal
Wang et al. The PI3K inhibitor buparlisib suppresses osteoclast formation and tumour cell growth in bone metastasis of lung cancer, as evidenced by multimodality molecular imaging
JP2023071181A (ja) 軟骨形成を誘導するための方法
Xie et al. JP4-039 protects chondrocytes from ferroptosis to attenuate osteoarthritis progression by promoting Pink1/Parkin-dependent mitophagy
US20150071919A1 (en) Cancer therapy
Li et al. Microenvironmental enzyme-responsive methotrexate modified quercetin micelles for the treatment of rheumatoid arthritis
Porter et al. Triamcinolone acetonide has minimal effect on short‐and long‐term metabolic activities of cartilage
MXPA04001868A (es) Uso de compuestos de pirrol anillados en el tratamiento de la degeneracion del hueso sub-condrial o cartilago articular.
Liang et al. Varespladib-Based Lipid Nanoparticles as Highly Efficient Anti-Inflammatory Agents for Osteoarthritis Treatment
WO2019157085A2 (en) INHIBITION OF WNT/β-CATENIN SIGNALING IN THE TREATMENT OF OSTEOARTHRITIS
ES2951306T3 (es) Utilización de compuesto en la preparación de fármaco para tratar la enfermedad de los vasos cerebrales pequeños
CA3004506C (en) Use of n-(5-(3-(7-(3- fluorophenyl)-3h-imidazo[4,5-c]pyridin-2-yl)-1h-indazol-5-yl)pyridin-3-yl)-3-methylbutanamide in the treatment of osteoarthritis
US20260048052A1 (en) Methods of treating tenosynovial giant cell tumors
玉行傅 et al. The effect of umbilical cord blood mononucleated cells on knee osteoarthritis in rabbits
Duan et al. Therapeutic effects of Tetramethylpyrazine on Cartilage in Rat Model of Post-traumatic Osteoarthritis
Lastakchi Development of novel combinational implants for the localised treatment of brain tumours
HK40045419A (en) Methods and compositions for killing senescent cells and for treating senescence-associated diseases and disorders
HK40063789B (zh) 大麻素酸酯组合物及其用途

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20191119

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20210413

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20230511

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20230717

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20230511

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I